PT  - JOURNAL ARTICLE
AU  - Gilmour, Kenneth McNair
AU  - Ramaesh, Kanna
TI  - Case for conservative management of adenoviral pseudomembranous conjunctivitis
AID  - 10.1136/bcr-2022-253014
DP  - 2023 Feb 01
TA  - BMJ Case Reports
PG  - e253014
VI  - 16
IP  - 2
4099  - http://casereports.bmj.com/content/16/2/e253014.short
4100  - http://casereports.bmj.com/content/16/2/e253014.full
SO  - BMJ Case Reports2023 Feb 01; 16
AB  - The clinical course of adenoviral pseudomembranous conjunctivitis is mostly self-limiting and requires only supportive management measures; however, a minority of patients may develop severe inflammation in response to the virus, which can present as subepithelial infiltrates and pseudomembranes. In its most severe form, symblepharon can result from the inflammatory response resulting in longer-term clinical sequelae. The optimal management of adenoviral pseudomembranous conjunctivitis is poorly defined and while debridement is commonly recommended, there is limited evidence base to support this practice. In this paper, we present two cases of PCR-proven adenoviral pseudomembranous conjunctivitis managed conservatively with topical lubricants and corticosteroids rather than debridement to good effect.